Published in Mol Cell Endocrinol on April 01, 1988
Differential expression of human placental growth-hormone variant and chorionic somatomammotropin in culture. Biochem J (1990) 0.81
Human chorionic somatomammotropin and growth hormone gene expression in rat pituitary tumour cells is dependent on proximal promoter sequences. Nucleic Acids Res (1989) 0.78
Role of nonexercise activity thermogenesis in resistance to fat gain in humans. Science (1999) 6.02
Structure and evolution of the growth hormone gene family. Endocr Rev (1983) 1.97
eNOS gene transfer to vascular smooth muscle cells inhibits cell proliferation via upregulation of p27 and p21 and not apoptosis. Cardiovasc Res (2000) 1.53
Adipocyte macrophage colony-stimulating factor is a mediator of adipose tissue growth. J Clin Invest (1998) 1.51
Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models. Lab Anim (2011) 1.43
Myogenic growth factor present in skeletal muscle is purified by heparin-affinity chromatography. Proc Natl Acad Sci U S A (1985) 1.25
Human islet amyloid polypeptide expression in COS-1 cells. A model of intracellular amyloidogenesis. Am J Pathol (1995) 1.20
Thyroid hormone receptors and responses. Recent Prog Horm Res (1979) 1.19
The epsilon subtype of protein kinase C is required for cardiomyocyte connexin-43 phosphorylation. Circ Res (2000) 1.18
S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin. Am J Pathol (2000) 1.18
The human growth hormone gene locus: structure, evolution, and allelic variations. DNA (1987) 1.12
Cooperative binding of TEF-1 to repeated GGAATG-related consensus elements with restricted spatial separation and orientation. DNA Cell Biol (2000) 1.11
Selective monoclonal antibody recognition and cellular localization of an unphosphorylated form of connexin43. Exp Cell Res (1997) 1.11
The human growth hormone gene contains both positive and negative control elements. J Biol Chem (1988) 1.11
Most multifocal papillary thyroid carcinomas acquire genetic and morphotype diversity through subclonal evolution following the intra-glandular spread of the initial neoplastic clone. J Pathol (2008) 1.10
A novel assay in vitro of human islet amyloid polypeptide amyloidogenesis and effects of insulin secretory vesicle peptides on amyloid formation. Biochem J (1998) 1.09
The primary structure of coho salmon growth hormone and its cDNA. Gen Comp Endocrinol (1987) 1.07
Small heat shock proteins inhibit in vitro A beta(1-42) amyloidogenesis. FEBS Lett (1997) 1.07
TEF-1 transrepression in BeWo cells is mediated through interactions with the TATA-binding protein, TBP. J Biol Chem (1996) 1.07
Overexpression of FGF-2 increases cardiac myocyte viability after injury in isolated mouse hearts. Am J Physiol Heart Circ Physiol (2001) 1.06
Analysis of a major human chorionic somatomammotropin gene. Evidence for two functional promoter elements. J Biol Chem (1984) 1.06
Intracellular amyloidogenesis by human islet amyloid polypeptide induces apoptosis in COS-1 cells. Am J Pathol (1999) 1.06
Leptin and leptin receptor expression in normal and neoplastic human pituitary: evidence of a regulatory role for leptin on pituitary cell proliferation. J Clin Endocrinol Metab (1999) 1.05
Human placental TEF-5 transactivates the human chorionic somatomammotropin gene enhancer. Mol Endocrinol (1999) 1.03
Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma. J Clin Endocrinol Metab (1997) 1.01
Mechanisms of glucocorticoid hormone action. J Steroid Biochem (1984) 1.01
Involvement of a protein distinct from transcription enhancer factor-1 (TEF-1) in mediating human chorionic somatomammotropin gene enhancer function through the GT-IIC enhanson in choriocarcinoma and COS cells. J Biol Chem (1995) 1.00
Selected muscle and nerve extracts contain an activity which stimulates myoblast proliferation and which is distinct from transferrin. Dev Biol (1985) 0.99
Thyroid hormone receptors. Alteration of hormone-binding specificity. J Biol Chem (1979) 0.98
DNA bending by retinoid X receptor-containing retinoid and thyroid hormone receptor complexes. Mol Cell Biol (1993) 0.98
Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation. J Clin Endocrinol Metab (1993) 0.97
The human chorionic somatomammotropin gene enhancer is composed of multiple DNA elements that are homologous to several SV40 enhansons. J Biol Chem (1994) 0.97
An initiator element is required for maximal human chorionic somatomammotropin gene promoter and enhancer function. J Biol Chem (1995) 0.97
Distinctive patterns of basic fibroblast growth factor (bFGF) distribution in degenerating and regenerating areas of dystrophic (mdx) striated muscles. Dev Biol (1991) 0.95
Adult cardiomyocytes express functional high-affinity receptors for basic fibroblast growth factor. Am J Physiol (1995) 0.95
The human growth hormone gene is negatively regulated by triiodothyronine when transfected into rat pituitary tumor cells. J Biol Chem (1986) 0.94
Hormonal domains of response: actions of glucocorticoid and thyroid hormones in regulating pleiotropic responses in cultured cells. Recent Prog Horm Res (1980) 0.92
Fibroblast growth factor-2 decreases metabolic coupling and stimulates phosphorylation as well as masking of connexin43 epitopes in cardiac myocytes. Circ Res (1996) 0.91
Two CGTCA motifs and a GHF1/Pit1 binding site mediate cAMP-dependent protein kinase A regulation of human growth hormone gene expression in rat anterior pituitary GC cells. J Biol Chem (1994) 0.90
Regulated expression of chimaeric genes containing the 5'-flanking regions of human growth hormone-related genes in transiently transfected rat anterior pituitary tumor cells. Nucleic Acids Res (1987) 0.90
Prenyltransferase from Saccharomyces cerevisiae. Purification to homogeneity and molecular properties. J Biol Chem (1975) 0.89
Affinity chromatography of thyroid hormone receptors. Biospecific elution from support matrices, characterization of the partially purified receptor. J Biol Chem (1981) 0.88
A micro-scale method to isolate DNA-binding proteins suitable for quantitative comparison of expression levels from transfected cells. Nucleic Acids Res (1995) 0.88
Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy. Cancer Gene Ther (2012) 0.88
alpha1-Adrenergic stimulation of FGF-2 promoter in cardiac myocytes and in adult transgenic mouse hearts. Am J Physiol (1999) 0.88
The 5'-flanking sequences of the human growth hormone gene contain a cell-specific control element. DNA (1986) 0.88
Thyroid hormone responsiveness in human growth hormone-related genes. Possible correlation with receptor-induced DNA conformational changes. J Biol Chem (1992) 0.86
Thyroid hormone resistance syndrome: correlation of dominant negative activity and location of mutations. J Clin Endocrinol Metab (1993) 0.86
Basic fibroblast growth factor is cardioprotective in ischemia-reperfusion injury. Mol Cell Biochem (1995) 0.86
Interaction of small nuclear ribonucleoproteins with simian virus 40 in CV-1 cells: is U2 snRNA involved in regulating replication? DNA (1984) 0.86
Interaction of cardiac myosin and its light chains with calcium ions and regulation of binding by phosphorylation. J Mol Cell Cardiol (1982) 0.85
Expression and hormonal regulation of the rat growth hormone gene in transfected mouse L cells. DNA (1984) 0.85
DNA binding of TEA/ATTS domain factors is regulated by protein kinase C phosphorylation in human choriocarcinoma cells. J Biol Chem (2001) 0.85
Lysophosphatidylethanolamine acyltransferase activity is elevated during cardiac cell differentiation. Biochim Biophys Acta (2000) 0.84
Glucocorticoid action: a mechanism involving nuclear and non-nuclear pathways. Br J Dermatol (1982) 0.84
Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors. Oncogene (1998) 0.84
Regulation of activity of chromatin receptors for thyroid hormone: possible involvement of histone-like proteins. Proc Natl Acad Sci U S A (1979) 0.84
Transforming growth factor-beta 1 induces growth inhibition of a human medullary thyroid carcinoma cell line despite an increase in steady state c-myc messenger ribonucleic acid levels. Endocrinology (1994) 0.84
Protection against myocardial ischemic/reperfusion injury by inhibitors of two separate pathways of Na+ entry. J Mol Cell Cardiol (1998) 0.84
Over-expression of CUG- or AUG-initiated forms of basic fibroblast growth factor in cardiac myocytes results in similar effects on mitosis and protein synthesis but distinct nuclear morphologies. J Mol Cell Cardiol (1994) 0.83
The human placental growth hormone variant is mitogenic for rat lymphoma Nb2 cells. Endocrinology (1990) 0.83
FGF-2-induced negative inotropism and cardioprotection are inhibited by chelerythrine: involvement of sarcolemmal calcium-independent protein kinase C. J Mol Cell Cardiol (1998) 0.83
Protein kinase C-epsilon mediates phorbol ester-induced phosphorylation of connexin-43. Cell Commun Adhes (2001) 0.82
Overexpression of long or short FGFR-1 results in FGF-2-mediated proliferation in neonatal cardiac myocyte cultures. Cardiovasc Res (1999) 0.82
Increased basic fibroblast growth factor (bFGF) accumulation and distinct patterns of localization in isoproterenol-induced cardiomyocyte injury. Growth Factors (1993) 0.82
Basic fibroblast growth factor stimulates connexin-43 expression and intercellular communication of cardiac fibroblasts. Mol Cell Biochem (1995) 0.82
Fast and slow chicken skeletal muscles contain different alpha and beta tropomyosins. Biochem Biophys Res Commun (1983) 0.81
Fluorescent rhodamine-labeled thyroid hormone derivatives: synthesis and binding to the thyroid hormone nuclear receptor. FEBS Lett (1979) 0.81
FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance. Clin Endocrinol (Oxf) (2000) 0.81
Estrogen receptor expression and growth-promoting function in human choriocarcinoma cells. DNA Cell Biol (1997) 0.81
Differential expression of human placental growth-hormone variant and chorionic somatomammotropin in culture. Biochem J (1990) 0.81
Regulation of human chorionic somatomammotropin gene expression in rat pituitary tumour cells. Mol Cell Endocrinol (1988) 0.80
A simple step to reduce background in E. coli transformations of blunt-ended plasmid ligation products. Biotechniques (1992) 0.80
The effects of hyperthyroidism on muscular dystrophy in the mdx mouse: greater dystrophy in cardiac and soleus muscle. Muscle Nerve (1994) 0.80
Mechanisms of glucocorticoid hormone action. Adv Exp Med Biol (1986) 0.80
Cellular and physiological mechanisms of new-onset diabetes mellitus after solid organ transplantation. Diabet Med (2012) 0.80
Leptin responses to overfeeding: relationship with body fat and nonexercise activity thermogenesis. J Clin Endocrinol Metab (1999) 0.80
The pituitary-muscle axis in mdx dystrophic mice. J Neurol Sci (1994) 0.80
Expression of a potential metastasis suppressor gene (nm23) in thyroid neoplasms. World J Surg (1994) 0.79
Expression of the PAX8/PPARγ Fusion Protein Is Associated with Decreased Neovascularization In Vivo: Impact on Tumorigenesis and Disease Prognosis. Genes Cancer (2010) 0.79
Immunolocalization of the sarcolemmal Ca2+/Mg2+ ecto-ATPase (myoglein) in rat myocardium. Mol Cell Biochem (1999) 0.79
Calcium protects pituitary basic fibroblast growth factors from limited proteolysis by co-purifying proteases. Biochem Biophys Res Commun (1990) 0.79
The human chorionic somatomammotropin enhancers form a composite silencer in pituitary cells in vitro. Mol Endocrinol (1997) 0.79
Expression of fibroblast growth factor receptor-1 in rat heart H9c2 myoblasts increases cell proliferation. Mol Cell Biochem (1997) 0.79
Basic fibroblast growth factor in rat brain: localization to glial gap junctions correlates with connexin43 distribution. Brain Res (1991) 0.79
Novel human TEF-1 isoforms exhibit altered DNA binding and functional properties. Biochemistry (2000) 0.79
Cloning and expression of fibroblast growth factor receptor-1 isoforms in the mouse heart: evidence for isoform switching during heart development. J Mol Cell Cardiol (1994) 0.79
Perinatal phenotype and hypothyroidism are associated with elevated levels of 21.5- to 22-kDa basic fibroblast growth factor in cardiac ventricles. Dev Biol (1993) 0.79
Remnant lipoproteins induce endothelial plasminogen activator inhibitor-1. Biochem Biophys Res Commun (2001) 0.78
Triiodothyronine nuclear receptors: an in vitro comparison of the binding of triiodothyronine to nuclei of adult rat liver, cerebral hemisphere, and anterior pituitary. Endocrinology (1978) 0.78
Elevation in phosphatidylethanolamine is an early but not essential event for cardiac cell differentiation. Exp Cell Res (2000) 0.78
Negative thyroid hormone control of human growth hormone gene expression is mediated by 3'-untranslated/3'-flanking DNA. J Biol Chem (1992) 0.78
Redifferentiation and induction of tumor suppressors miR-122 and miR-375 by the PAX8/PPARγ fusion protein inhibits anaplastic thyroid cancer: a novel therapeutic strategy. Cancer Gene Ther (2013) 0.78
Human chorionic somatomammotropin and growth hormone gene expression in rat pituitary tumour cells is dependent on proximal promoter sequences. Nucleic Acids Res (1989) 0.78
CUG-initiated FGF-2 induces chromatin compaction in cultured cardiac myocytes and in vitro. J Cell Physiol (2001) 0.78
Effect of "enhancer" sequences on ventricular myosin light chain-2 promoter activity in heart muscle and nonmuscle cells. Biochem Biophys Res Commun (1995) 0.77
Malate dehydrogenase, circular dichroism difference spectra of porcine heart mitochondrial and supernatant enzymes, binary enzyme-coenzyme, and ternary enzyme-coenzyme-substrate analog complexes. J Biol Chem (1975) 0.77
ONYX-411, a conditionally replicative oncolytic adenovirus, induces cell death in anaplastic thyroid carcinoma cell lines and suppresses the growth of xenograft tumors in nude mice. Cancer Gene Ther (2008) 0.77
Antitumor Activity of VB-111, a Novel Antiangiogenic Virotherapeutic, in Thyroid Cancer Xenograft Mouse Models. Genes Cancer (2011) 0.77